These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34818480)

  • 21. EPAS1-related pheochromocytoma/paraganglioma.
    Alzahrani AS; Alswailem M; Buffet A; Alghamdi B; Alobaid L; Alsagheir O; Al-Hindi H; Pacak K
    Endocr Relat Cancer; 2024 Aug; 31(8):. PubMed ID: 38767322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas.
    Toledo RA; Qin Y; Srikantan S; Morales NP; Li Q; Deng Y; Kim SW; Pereira MA; Toledo SP; Su X; Aguiar RC; Dahia PL
    Endocr Relat Cancer; 2013 Jun; 20(3):349-59. PubMed ID: 23533246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas.
    Bechmann N; Moskopp ML; Ullrich M; Calsina B; Wallace PW; Richter S; Friedemann M; Langton K; Fliedner SMJ; Timmers HJLM; Nölting S; Beuschlein F; Fassnacht M; Prejbisz A; Pacak K; Ghayee HK; Bornstein SR; Dieterich P; Pietzsch J; Wielockx B; Robledo M; Qin N; Eisenhofer G
    Endocr Relat Cancer; 2020 Nov; 27(11):625-640. PubMed ID: 33112842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Novel Mutations and Expressions of
    Islam F; Pillai S; Gopalan V; Lam AK
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental vascular malformations in EPAS1 gain-of-function syndrome.
    Rosenblum JS; Wang H; Dmitriev PM; Cappadona AJ; Mastorakos P; Xu C; Jha A; Edwards N; Donahue DR; Munasinghe J; Nazari MA; Knutsen RH; Rosenblum BR; Smirniotopoulos JG; Pappo A; Spetzler RF; Vortmeyer A; Gilbert MR; McGavern DB; Chew E; Kozel BA; Heiss JD; Zhuang Z; Pacak K
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33497361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas.
    Yang C; Sun MG; Matro J; Huynh TT; Rahimpour S; Prchal JT; Lechan R; Lonser R; Pacak K; Zhuang Z
    Blood; 2013 Mar; 121(13):2563-6. PubMed ID: 23361906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular manifestations of hypoxia-inducible factor-2α paraganglioma-somatostatinoma-polycythemia syndrome.
    Pacak K; Chew EY; Pappo AS; Yang C; Lorenzo FR; Wilson MW; Aronow MB; Young JA; Popovic V; Zhuang Z
    Ophthalmology; 2014 Nov; 121(11):2291-3. PubMed ID: 25109928
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.
    Comino-Méndez I; de Cubas AA; Bernal C; Álvarez-Escolá C; Sánchez-Malo C; Ramírez-Tortosa CL; Pedrinaci S; Rapizzi E; Ercolino T; Bernini G; Bacca A; Letón R; Pita G; Alonso MR; Leandro-García LJ; Gómez-Graña A; Inglada-Pérez L; Mancikova V; Rodríguez-Antona C; Mannelli M; Robledo M; Cascón A
    Hum Mol Genet; 2013 Jun; 22(11):2169-76. PubMed ID: 23418310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
    Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
    Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Belzutifan, HIF-2α Inhibitor, and Clear Cell Renal Cell Carcinoma With Somatic Von-Hippel-Lindau Loss-of-Function Mutation.
    Chan KH; Li N; Lador R; Amsbaugh M; Gonzalez A; Cen P
    J Investig Med High Impact Case Rep; 2024; 12():23247096241231641. PubMed ID: 38344974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors.
    Toledo R; Jimenez C
    F1000Res; 2018; 7():. PubMed ID: 30109021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Rare Case of Paraganglioma Syndrome Associated With Polycythemia and Blindness.
    Esaki Y; Liao X; Harbuz-Miller I
    Cureus; 2024 Jun; 16(6):e63047. PubMed ID: 39050329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma.
    Lorenzo FR; Yang C; Ng Tang Fui M; Vankayalapati H; Zhuang Z; Huynh T; Grossmann M; Pacak K; Prchal JT
    J Mol Med (Berl); 2013 Apr; 91(4):507-12. PubMed ID: 23090011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIF2 and endocrine neoplasia: an evolving story.
    Maher ER
    Endocr Relat Cancer; 2013 Jun; 20(3):C5-7. PubMed ID: 23653463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIF-2alpha: Achilles' heel of pseudohypoxic subtype paraganglioma and other related conditions.
    Tella SH; Taïeb D; Pacak K
    Eur J Cancer; 2017 Nov; 86():1-4. PubMed ID: 28946040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological HIF2α inhibition improves VHL disease-associated phenotypes in zebrafish model.
    Metelo AM; Noonan HR; Li X; Jin Y; Baker R; Kamentsky L; Zhang Y; van Rooijen E; Shin J; Carpenter AE; Yeh JR; Peterson RT; Iliopoulos O
    J Clin Invest; 2015 May; 125(5):1987-97. PubMed ID: 25866969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatic Mosaicism of EPAS1 Mutations in Pacak-Zhuang Syndrome.
    Wang H; Zhuang Z; Rosenblum JS; Pacak K
    Endocr Pract; 2022 Jul; 28(7):734-735. PubMed ID: 35489703
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis.
    Choueiri TK; Bauer TM; Papadopoulos KP; Plimack ER; Merchan JR; McDermott DF; Michaelson MD; Appleman LJ; Thamake S; Perini RF; Zojwalla NJ; Jonasch E
    Nat Med; 2021 May; 27(5):802-805. PubMed ID: 33888901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital Cyanotic Heart Disease and the Association with Pheochromocytomas and Paragangliomas.
    Jones RB; Cohen DL
    Curr Cardiol Rep; 2023 Nov; 25(11):1451-1460. PubMed ID: 37847359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional significance of germline EPAS1 variants.
    Dwight T; Kim E; Bastard K; Benn DE; Eisenhofer G; Richter S; Mannelli M; Rapizzi E; Prejbisz A; Pęczkowska M; Pacak K; Clifton-Bligh R
    Endocr Relat Cancer; 2021 Feb; 28(2):97-109. PubMed ID: 33300499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.